Dendritcellebaseret cancervaccine

3 Citationer (Scopus)

Abstract

The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients.
Udgivelsesdato: 2006-Apr-3
Bidragets oversatte titelDendritic cell-based cancer vaccine
OriginalsprogDansk
TidsskriftUgeskrift for læger
Vol/bind168
Udgave nummer14
Sider (fra-til)1420-3
Antal sider3
ISSN0041-5782
StatusUdgivet - 2006

Citationsformater